About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Houston | 424 Studies

Clinical Trials Pancreatic CancerHouston

Pancreatic Cancer Clinical Trials in Houston

Find 424 clinical trials for pancreatic cancer near Houston, Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 361-380 of 424 trials

CompletedStudy of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15.NCT05546476·Conway, Arkansas and 77 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingAn Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibThe purpose of this study is to provide continued supply of ruxolitinib alone, ruxolitinib plus background cancer therapy, or background cancer therapy alone to subjects from an…NCT02955940·Santa Monica, California and 8 others

TerminatedPF-06952229 Treatment in Adult Patients With Advanced Solid TumorsA Phase 1 dose escalation and expansion study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors.NCT03685591·Scottsdale, Arizona and 14 others

Active not recruitingA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsThis phase II trial studies cediranib maleate in combination with olaparib in treating patients with solid tumors that have spread to other parts of the body (advanced/metastatic)…NCT02498613·La Jolla, California and 15 others

CompletedIdentifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic CancerThe goal of this clinical research study is to learn about symptoms related to chemotherapy and the disease, in patients with advanced pancreatic cancer.NCT00805688·Houston, Texas

RecruitingComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated BiomarkersThe purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers.NCT04239573·Birmingham, Alabama and 428 others

TerminatedPhase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic CancerTo evaluate the safety and efficacy of ACP-196 and nab paclitaxel/gemcitabine in subjects with previously untreated metastatic pancreatic cancer using standard response criteriaNCT02570711·Ventura, California and 9 others

RecruitingStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT06084481·Duarte, California and 53 others

Active not recruitingStudy of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyThis study aims to determine the safety, pharmacokinetics (PK) and recommended Phase 3 dose (RP3D) of RYZ101 in Part 1, and the safety, efficacy, and PK of RYZ101 compared with…NCT05477576·Phoenix, Arizona and 53 others

Active not recruitingAtezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsThis phase II trial studies how well atezolizumab and bevacizumab work in treating patients with rare solid tumors.NCT03074513·Houston, Texas

Active not recruitingPersonalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal CancerThis phase I trial studies the side effects and best way to give personalized peptide vaccine in patients with pancreatic or colorectal cancer that has spread to other places in…NCT02600949·Houston, Texas

TerminatedNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsThe purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors and a pathogenic or likely…NCT05169437·Yuma, Arizona and 79 others

CompletedDolastatin 10 in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003677·Chicago, Illinois and 1 other

WithdrawnPembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic CancerThis phase II trial studies how well pembrolizumab and PEGPH20 work in treating patients with pancreatic cancer that has spread to other places in the body (metastatic).NCT04058964·Houston, Texas

Active not recruiting18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsThis early phase I trial studies how well 18F-fluoroazomycin arabinoside positron emission tomography (PET)-computed tomography (CT) works in diagnosing solid tumors.NCT03168737·Houston, Texas

UnknownStudy of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesStudy of NGM707 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesNCT04913337·Los Angeles, California and 26 others

RecruitingA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatigueStudy to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for the first-line treatment in…NCT06989437·Birmingham, Alabama and 229 others

CompletedA Study of ASN007 in Patients With Advanced Solid TumorsThe study is divided into two parts. The first part of the study will test various doses of ASN007 to find out the highest safe dose to test in five specific groups.NCT03415126·Tampa, Florida and 4 others

RecruitingA Study to Determine the Effect of CT3001 in Patients With Advanced Solid TumorsThis is an FIH, multicenter, open-label, dose escalation and dose expansion/dose optimization study of CT3001, which will be conducted in 2 phases: Phase 1 and Phase 2b.NCT06598007·Houston, Texas

RecruitingA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsThe purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder, lung, head and neck…NCT07090499·Duarte, California and 30 others

PreviousPage 19 of 22Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia